- Home
- CRL vs FCFS Comparison
CRL vs FCFS Comparison
Compare CRL & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- FCFS
- Stock Information
- Founded
- CRL 1947
- FCFS 1988
- Country
- CRL United States
- FCFS United States
- Employees
- CRL N/A
- FCFS N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- FCFS Other Specialty Stores
- Sector
- CRL Health Care
- FCFS Consumer Discretionary
- Exchange
- CRL Nasdaq
- FCFS Nasdaq
- Market Cap
- CRL 7.3B
- FCFS 6.7B
- IPO Year
- CRL 2000
- FCFS 1991
- Fundamental
- Price
- CRL $198.10
- FCFS $154.35
- Analyst Decision
- CRL Buy
- FCFS Strong Buy
- Analyst Count
- CRL 16
- FCFS 4
- Target Price
- CRL $190.86
- FCFS $153.00
- AVG Volume (30 Days)
- CRL 1.0M
- FCFS 328.7K
- Earning Date
- CRL 11-05-2025
- FCFS 10-30-2025
- Dividend Yield
- CRL N/A
- FCFS 1.09%
- EPS Growth
- CRL N/A
- FCFS 24.22
- EPS
- CRL N/A
- FCFS 6.50
- Revenue
- CRL $4,028,615,000.00
- FCFS $3,388,177,000.00
- Revenue This Year
- CRL N/A
- FCFS $4.03
- Revenue Next Year
- CRL $2.43
- FCFS $8.06
- P/E Ratio
- CRL N/A
- FCFS $23.70
- Revenue Growth
- CRL N/A
- FCFS 2.49
- 52 Week Low
- CRL $91.86
- FCFS $100.24
- 52 Week High
- CRL $230.02
- FCFS $163.01
- Technical
- Relative Strength Index (RSI)
- CRL 76.81
- FCFS 52.19
- Support Level
- CRL $184.88
- FCFS $150.06
- Resistance Level
- CRL $174.73
- FCFS $163.01
- Average True Range (ATR)
- CRL 5.97
- FCFS 4.27
- MACD
- CRL 2.36
- FCFS -0.65
- Stochastic Oscillator
- CRL 95.23
- FCFS 33.13
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.